查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1864448

按技术、产品、应用、最终用户和自动化程度分類的自动化微生物市场—2025-2032年全球预测

Automated Microbiology Market by Technology, Product, Application, End User, Automation Level - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，自动化微生物市场规模将达到 317.9 亿美元，复合年增长率为 12.36%。

关键市场统计数据
基准年 2024 125.1亿美元
预计年份：2025年 140.3亿美元
预测年份 2032 317.9亿美元
复合年增长率 (%) 12.36%

实验室主任的自动化微生物学策略指南：确定技术整合、营运重点和实际实施路径

自动化微生物学已从一种小众的实验室辅助工具发展成为扩充性、可靠的诊断和分析工作流程的核心基础。光学成像、分子检测、质谱和资讯科学的进步融合在一起，加快了结果获取速度，减少了人为误差，并在临床诊断、食品安全、环境监测和生物製药品管等领域开闢了新的应用情境。随着实验室面临检体量不断增加、监管要求日益严格以及训练有素的技术人员短缺等挑战，对自动化的投资正在提高检测通量和可重复性，并重塑实验室的营运重点。

本执行摘要概述了当前行业格局，整合了对企业高管和实验室负责人至关重要的技术趋势、商业性动态和营运考虑。它重点阐述了诸如可将资料传输至下游数位分析的自动化菌落计数器以及可减少人工操作时间的整合定序工作流程等渐进式创新如何创造协同效应和新的价值提案。同样重要的是系统级集成，即将仪器连接到实验室资讯管理系统和数位仪表板，从而实现即时决策支援。本报告说明实际实施管治，包括试点设计、检验考虑和跨职能管理，以确保自动化解决方案在不影响核心品管的前提下，带来可衡量的改进。

目标是为决策者提供清晰、可操作的视角，了解自动化微生物学能力目前处于什么状态，它们可能如何在营运环境中实施，以及哪些组织槓桿可以加快实施速度，同时保持合规性以及临床和分析准确性。

分子检测、质谱、智慧软体和供应链设计等领域的进步如何融合，正在重新定义实验室自动化策略

自动化微生物学领域正受到多项变革性变化的重塑，这些变化共同改变了实验室评估价值和衡量绩效的方式。其中一个关键驱动因素是分子技术的进步，这些技术已超越概念验证阶段，发展成为实用且整合的工作流程。次世代定序和先进的PCR平台正日益被纳入常规诊断和监测实践中，它们作为传统培养方法的补充而非替代。同时，质谱鑑定技术的改进和高通量流式细胞技术的进步，拓展了可快速、可重复分析的微生物种类和检体类型。

同时，软体和系统整合已成为关键的差异化因素。实验室资讯管理系统 (LIMS) 和整合仪器套件实现了闭合迴路工作流程，其中检体元资料、仪器输出和品管记录同步，从而加快了根本原因分析并提高了法规遵循的可追溯性。人工智慧和机器学习正越来越多地应用于基于影像的菌落计数和频谱解释，在改进自动决策规则的同时，减少了人工标註的需求。供应链的韧性和试剂的可用性促进了模组化自动化方法的实施，使实验室能够根据自身工作流程的成熟度，选择性地扩展规模，最初使用半自动仪器，然后过渡到全自动平台。

监管和报销途径也在不断演变，监管机构越来越重视自动化系统的可追溯性、方法检验和上市后监测。这些变化正在创造一种环境，在这种环境下，自动化决策受到临床和分析需求、营运限制以及软体和耗材伙伴关係生态系统方法的综合驱动。

关税累积变化导致的营运和采购调整正在影响筹资策略、总体拥有成本考量和应对措施。

贸易政策发展和关税调整措施（将持续到2025年）正对测试设备、耗材和整合系统的采购和实施产生累积影响。进口零件和成品设备关税上涨导致成本增加，促使采购部门重新评估供应商组合，强调签订长期合约以降低价格波动风险，并考虑优先选择区域製造地和拥有国内库存的经销商等替代筹资策略。这种转变使得采购部门更加关注总体拥有成本而非仅仅关注采购价格，前置作业时间、服务能力和备件供应情况在采购决策中变得越来越重要。

为因应此局面，製造商和经销商正采取多种措施，例如本地组装、选择性地对受关税影响较小的组件进行设计变更，以及增加国内仓库中关键试剂和任务关键型备件的储备。实验室在资本支出方面变得更加谨慎，倾向于采用可逐步升级的模组化系统。生命週期管理技术，例如多站点服务合约和耗材共用协议，正被用于分散财务风险并维持业务连续性。

事实上，关税带来的变化正在加速关于战略韧性的讨论，包括确保关键部件的多元化来源、投资于供应商中立接口以最大限度地减少对供应商的依赖，以及加强监管文件以加快替代供应商的资格认证。这些措施，加上采购和财务部门的先进情境规划，正在帮助实验室适应跨境贸易政策成为产业计画关键因素的商业环境。

一种基于精细细分的观点，将技术平台、产品类型、实验室应用和自动化成熟度与实际应用模式连结起来。

详细的細項分析揭示了不同技术、产品、应用、最终用户和自动化程度下，采用模式和价值驱动因素的差异。在技​​术方面，基于培养的方法仍然是表型确认的核心，并透过自动化菌落计数器、自动化培养系统以及自动化染色和显微镜技术不断优化，从而减少人工操作时间并提高可重复性。流式细胞技术可在环境和临床应用中提供快速的细胞和颗粒分析，而质谱分析则能够可靠地鑑定复杂样本。诸如微阵列、次世代定序和PCR/即时PCR分子生物学方法正在拓展诊断范围，实现先前难以大规模应用的基因组监测和多重检测。

产品细分突出了耗材和试剂、仪器和软体以及服务的不同商业性和营运考虑。整合系统、实验室资讯管理系统和独立仪器具有不同的实施规模和验证要求，这会影响采购週期和服务模式。按应用细分，学术和研究机构优先考虑用于方法开发的灵活研究级平台；临床诊断需要针对遗传性疾病、感染疾病和肿瘤疾病的稳健且检验的工作流程；环境检测和食品饮料行业优先考虑通量和法规可追溯性；而製药和生物技术用户则优先考虑合规性和批次级质量保证。

最终用户涵盖学术研究机构、医院和诊断实验室、食品饮料公司、製药公司以及参考实验室等。医院和诊断实验室通常进一步细分为诊所、私立医院和公立医院，每种类型的医院都有不同的预算限制、法规结构和吞吐量需求。最后，自动化程度（全自动或半自动）是一个关键选择，取决于实验室的规模、技术专长和可用资金。许多机构采用混合策略，先使用半自动模组，然后再过渡到全自动系统。

区域监管差异、基础设施投资和经销伙伴关係如何影响美洲、欧洲、中东和非洲以及亚太地区的采用路径

区域趋势将对美洲、欧洲、中东和非洲以及亚太地区自动化微生物技术的应用、监管路径和商业策略产生重大影响。在美洲，需求受制于多元化的医疗基础设施、集中的临床卓越中心以及能够支援大规模自动化部署的一体化医院网路。北美采购团队优先考虑与医院资讯系统的互通性以及对当地监管要求的合规性，而拉丁美洲市场的特点是集中式参考实验室与新兴的分散式检查需求并存，这正在影响产品组合和服务模式。

欧洲、中东和非洲地区（EMEA）的法规环境和市场环境各不相同，因此很难采用统一的市场策略。西欧市场率先采用整合检测系统，并高度重视正式的方法检验和跨国品质协调。该地区法规结构迫使供应商对临床证据和服务交付进行本地化。该地区的新兴市场可能优先考虑成本效益高的半自动化解决方案，这些方案允许逐步扩展产能，并且符合公共卫生政策。

亚太地区以其快速的基础设施投资、强大的製造业生态系统以及对基因组学和分子诊断日益增长的需求而闻名。其应用模式涵盖了从实施全自动定序和质谱分析流程的先进都市区参考中心，到选择紧凑型半自动化平台的分散式临床机构。在所有地区，供应商与当地经销商之间的策略伙伴关係，以及对本地技术支援和培训的投入，都是持续应用和提升营运绩效的关键推动因素。

在竞争与合作并存的动态中，产品效能、软体整合、检验支援和服务模式将决定产品的长期市场接受度和供应商偏好。

自动化微生物学领域的竞争格局呈现出混合型结构，包括专业仪器製造商、整合式系统供应商、试剂和耗材供应商以及服务机构。市场领导透过仪器性能、软体整合、验证支援以及能够最大限度减少停机时间并确保可追溯性的全球服务网路来脱颖而出。仪器原始设备製造商 (OEM) 与试剂合作伙伴之间的策略联盟日益普遍，这种捆绑式服务简化了采购和验证流程，但也引发了人们对供应商锁定和互通性的担忧。

创新正在多个层面展开：硬体层面，更紧凑、模组化的仪器专为分散式环境而设计；检测层面，多重分子检测和稳健的样品製备化学方法不断涌现；软体层面，分析功能、品管演算法以及与实验室资讯管理系统 (LIMS) 的集成，都旨在提升营运价值。服务模式也在不断演变，延长保固期、基于绩效的服务协议以及云端远距离诊断已成为高通量实验室的标准配备。拥有深厚专业知识和可扩展支援基础设施的公司正成为参考实验室和医院网路的首选，而专注于独特检测能力和成本优化工作流程的创新企业则继续开拓专业市场。

与学术机构建立合作关係并参与多中心检验研究对于商业性信誉至关重要，尤其对于那些影响临床决策的技术而言更是如此。在竞争日益激烈的市场环境中，那些优先考虑开放架构、透明检验资料和终端使用者培训的供应商将更有利于将试验计画转化为长期应用。

为领导者提供实用且具战术性的建议，这些建议结合了渐进式自动化、采购弹性、互通性、劳动力发展和伙伴关係策略。

行业领导者应采取一系列综合措施，使技术选择与营运韧性和监管准备保持一致。首先，应采取分阶段的自动化策略，先进行试点部署，检验工作流程整合、方法可转移性和员工培训需求，然后再扩展到完整的自动化套件。这可以降低部署风险，并随着侦测需求和供应链状况的变化而保持灵活性。其次，在设计采购和合约方案时，应强调整体拥有成本、可预测的服务水准以及明确的备件和试剂供应承诺，以降低关税和物流波动带来的风险。

第三，从一开始就投资于软体和数据互通性，以确保与实验室资讯管理系统、电子健康记录（如适用）以及用于效能监控的中央仪表板无缝整合。开放介面和标准化资料格式可降低长期整合成本，并支援多供应商环境。第四，优先考虑员工发展，并将培训计划、能力评估和交叉培训纳入实施计划，以确保实验室人员能够管理自动化工作流程、解读结果和维护设备。

最后，与检验合作伙伴、区域服务供应商和监管顾问建立策略联盟，以加速市场准入并确保合规性。制定情境规划，考虑贸易政策变化、试剂供应中断和人员限制等因素，有助于经营团队在速度、可靠性和可追溯性带来竞争优势的市场环境中，保持业务连续性并做出明智的资本配置决策。

采用严谨的混合调查方法，结合关键相关人员的访谈、同侪审查的技术证据以及有针对性的技术和商业性评估。

本执行摘要的研究结合了对实验室主任、采购人员、临床病理学家和高级研发科学家的定性访谈，以及对技术文献、监管指导文件和产品技术资料的系统性回顾。主要访谈着重于实际应用中的挑战，例如检体处理量差异、人员能力和维护物流，旨在揭示操作挑战、检验方法和采购行为。次要来源的选择调查方法的严谨性，包括同行评审的研究、已发布的监管指南和供应商技术规范，以验证有关性能和预期用途的说法。

我们的分析方法优先考虑对定性研究结果和已记录的技术证据进行交叉检验，以确保建议基于可观察的实践而非供应商的说法。我们的技术评估着重考察了检测性能特征、週转时间、整合要求和标准服务覆盖范围。我们的商业分析则着重于影响实施时间的采购因素、合约结​​构和分销模式。在条件允许的情况下，我们纳入了多中心检验研究和临床性能评估的证据，以评估其在不同检测环境下的稳健性。

本调查方法的限制包括不同司法管辖区报告细则的差异以及软体功能的不断演变（其变化速度可能快于硬体更新周期）。为弥补这些局限性，分析重点关注持续存在的营运和策略主题，并建议在进行大规模部署之前进行有针对性的试点研究，以检验在实际应用中的表现。

将战略要务和营运实际情况结合，从而在临床、工业和研究实验室中成功实施自动化。

自动化微生物学正处于一个转折点，技术成熟度、营运压力和监管要求在此交汇，对实验室决策者提出了新的要求。改进的分子检测工作流程、先进的鑑定技术和更智慧的软体生态系统正在共同推动临床、工业和研究领域更可靠、扩充性的检测。儘管不同应用、最终用户和地理环境的采用路径仍会有所不同，但互通性、供应链韧性、员工准备和检验等通用要素将始终是成功实施的关键。

经营团队和检验负责人应将自动化视为组织转型，而不仅仅是技术升级。这需要周密的变革管理、跨职能的管治以及循序渐进的风险缓解。在关税和贸易政策使采购复杂化的情况下，应优先考虑采购和合约设计的灵活性，以确保营运的连续性。最终，能够将自动化投资转化为可衡量改进的检验机构，将是那些将谨慎的试点、严格的检验和持续的培训与支持长期可维护性和合规性的战略伙伴关係关係相结合的机构。

本文彙编的见解指南策略规划，并提供切实可行的步骤，以加快实现自动化效益，同时保障品质和营运弹性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 利用人工智慧和机器学习演算法进行快速微生物鑑定和抗菌药物敏感性测试
  • 将机器人和自动化平台整合到临床微生物实验室中，以简化样本製备工作流程
  • 开发云端基础的数据分析解决方案，实现微生物检测结果的即时监控和远端存取。
  • 多重微流体系统的出现使得在单次检测中同时检测多种病原体成为可能。
  • 监管核准和标准化措施促进诊断实验室采用自动化系统

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 自动化微生物市场：依技术划分

  • 文化基础
    • 自动菌落计数器
    • 自动化培养系统
    • 自动化染色和显微镜
  • 流式细胞技术
  • 质谱分析
  • 分子碱
    • 微阵列
    • 次世代定序
    • PCR/即时PCR

第九章 自动化微生物市场：依产品划分

  • 耗材和试剂
  • 设备和软体
    • 整合系统
    • 实验室资讯管理系统
    • 独立设备
  • 服务

第十章 自动化微生物市场：依应用领域划分

  • 学术和研究领域
  • 临床诊断
    • 遗传性疾病
    • 感染疾病
    • 肿瘤学
  • 环境测试
  • 食品/饮料
  • 製药和生物技术

第十一章：按最终用户分類的自动化微生物市场

  • 学术和研究机构
  • 食品和饮料製造商
  • 医院和诊断实验室
    • 诊所
    • 私立医院
    • 公立医院
  • 製药公司
  • 参考检验机构

12. 依自动化程度分類的自动化微生物市场

  • 全自动
  • 半自动

第十三章：按地区分類的自动化微生物市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 按组别分類的自动化微生物市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国自动化微生物市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • bioMerieux SA
    • Becton, Dickinson and Company
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Siemens Healthineers AG
    • Merck KGaA
    • Sysmex Corporation
    • PerkinElmer, Inc.
    • bio-Rad Laboratories, Inc.
    • Abbott Laboratories
Product Code: MRR-F97DD5A7DBA7

The Automated Microbiology Market is projected to grow by USD 31.79 billion at a CAGR of 12.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 12.51 billion
Estimated Year [2025] USD 14.03 billion
Forecast Year [2032] USD 31.79 billion
CAGR (%) 12.36%

A strategic orientation to automated microbiology that clarifies technology convergence, operational priorities, and practical adoption pathways for laboratory leaders

Automated microbiology has evolved from a niche laboratory enhancement into a core enabler of scalable, reliable diagnostic and analytical workflows. Advances across optical imaging, molecular detection, mass spectrometry, and informatics have converged to shorten time-to-result, reduce human variability, and unlock new use cases in clinical diagnostics, food safety, environmental monitoring, and biopharmaceutical quality control. As laboratories contend with increasing sample volumes, tighter regulatory demands, and a shortage of trained technicians, automation investments deliver both throughput and reproducibility gains, reshaping operational priorities.

This executive summary frames the current landscape by synthesizing technology trajectories, commercial dynamics, and operational considerations that matter to C-suite and laboratory leaders. It identifies how incremental innovations-such as automated colony counters that feed downstream digital analysis, or integrated sequencing workflows that reduce hands-on time-are compounding to create new value propositions. Equally important are the system-level integrations that connect instruments to laboratory information management systems and digital dashboards, enabling real-time decision support. Throughout, emphasis is placed on practical adoption pathways: pilot designs, validation considerations, and cross-functional governance that ensure automated solutions deliver measurable improvements without disrupting core quality controls.

The objective is to equip decision-makers with a clear, actionable view of where automated microbiology capabilities are today, how they are likely to be deployed in operational settings, and which organizational levers accelerate adoption while maintaining compliance and clinical or analytical fidelity.

How converging advances in molecular assays, mass spectrometry, intelligent software, and supply chain design are redefining laboratory automation strategies

The automated microbiology landscape is being reshaped by several transformative shifts that collectively alter how laboratories assess value and measure performance. A primary driver is the maturation of molecular technologies that have moved beyond proof-of-concept to practical, integrated workflows; next-generation sequencing and advanced PCR platforms are increasingly embedded within routine diagnostic and surveillance pipelines, complementing classical culture-based methods rather than replacing them. At the same time, improvements in mass spectrometry identification and high-throughput flow cytometry have expanded the breadth of organisms and sample types that can be analyzed rapidly and reproducibly.

Concurrently, software and systems integration have become decisive differentiators. Laboratory information management systems and integrated instrument suites now enable closed-loop workflows where sample metadata, instrument outputs, and quality control records are synchronized, enabling faster root-cause analysis and regulatory traceability. Artificial intelligence and machine learning are making early inroads into image-based colony counting and spectral interpretation, improving automated decision rules while lowering the need for manual annotation. Supply chain resilience and reagent availability are stimulating modular automation approaches that let laboratories scale selectively, adopting semi-automated instruments initially before migrating to fully automated platforms as workflows mature.

Regulatory and reimbursement pathways are also evolving; agencies are placing greater emphasis on traceability, method validation, and post-market surveillance of automated systems. Together, these shifts are converging to create an environment where automation decisions are driven by a combination of clinical or analytical need, operational constraints, and an ecosystem approach to software and consumable partnerships.

Operational and procurement adjustments driven by cumulative tariff changes that are shaping sourcing strategies, total cost of ownership thinking, and resilience measures

Trade policy developments and tariff adjustments enacted through 2025 have had a cumulative effect on the procurement and deployment of laboratory instruments, consumables, and integrated systems. Tariff-induced cost increases for imported components and finished instruments have prompted procurement teams to reassess supplier portfolios, emphasize long-term contracts to mitigate price volatility, and consider alternative sourcing strategies that prioritize regional manufacturing or distributors with established domestic inventories. This shift has also heightened attention to total cost of ownership rather than headline purchase price, as lead times, servicing arrangements, and spare parts availability factor more prominently into procurement decisions.

Manufacturers and distributors have responded with a range of adaptations, including localized assembly, selective redesign to reduce tariff-sensitive content, and increased stocking of critical reagents and mission-critical spare parts within domestic warehouses. For laboratories, the net effect is a more cautious approach to capital expenditures and a preference for modular systems that can be upgraded incrementally. Lifecycle management practices, such as multi-site service agreements and shared consumable contracts, are being used to spread financial risk and maintain continuity of operations.

In practice, tariff-driven changes have accelerated conversations around strategic resilience: dual-sourcing critical components, investing in vendor-agnostic interfaces to minimize lock-in, and enhancing regulatory documentation to facilitate faster qualification of alternate suppliers. These measures, combined with more sophisticated scenario planning by procurement and finance teams, are helping laboratories adapt to a commercial environment in which cross-border trade policy is a material factor in operational planning.

A nuanced segmentation-driven perspective that connects technology platforms, product types, laboratory applications, and automation maturity to real-world adoption patterns

Deep segmentation analysis reveals differentiated adoption patterns and value drivers across technology, product, application, end user, and automation level axes. On the technology front, culture-based approaches remain central for phenotypic confirmation and are increasingly optimized through automated colony counters, automated culture systems, and automated staining and microscopy that reduce hands-on time and improve reproducibility. Flow cytometry provides rapid cellular and particulate analysis for environmental and clinical applications, while mass spectrometry offers high-confidence identification for complex samples. Molecular-based modalities such as microarray, next-generation sequencing, and PCR/real-time PCR are expanding diagnostic reach, enabling genomic surveillance and multiplexed detection that were previously impractical at scale.

Product segmentation highlights distinct commercial and operational considerations for consumables and reagents, instruments and software, and services. Integrated systems, laboratory information management systems, and standalone instruments present different implementation footprints and validation requirements, influencing procurement cycles and service models. Application-based segmentation shows that academic and research settings prioritize flexible, research-grade platforms for method development; clinical diagnostics demand robust, validated workflows for genetic disorders, infectious diseases, and oncology; environmental testing and food and beverage sectors emphasize throughput and regulatory traceability; while pharmaceutical and biotechnology users prioritize compliance and batch-level assurance.

End users range from academic and research institutions to hospitals and diagnostic laboratories, food and beverage companies, pharmaceutical firms, and reference laboratories. Hospitals and diagnostic labs often subdivide into clinics, private hospitals, and public hospitals, each with distinct budgetary constraints, regulatory frameworks, and throughput needs. Finally, automation level-whether fully automated or semi-automated-remains a decisive choice driven by laboratory scale, technical expertise, and capital availability, with many organizations adopting hybrid strategies that combine semi-automated modules during transition phases before committing to fully automated suites.

How regional regulatory diversity, infrastructure investment, and distribution partnerships shape distinct adoption pathways across the Americas, Europe Middle East and Africa, and Asia-Pacific

Regional dynamics materially influence technology adoption, regulatory pathways, and commercial strategies in automated microbiology across the Americas, Europe Middle East and Africa, and Asia-Pacific. In the Americas, demand is often shaped by healthcare infrastructure heterogeneity, concentrated centers of clinical excellence, and integrated hospital networks that can support larger-scale automation rollouts. North American procurement teams emphasize interoperability with hospital information systems and compliance with regional regulatory expectations, while Latin American markets are characterized by a mix of centralized reference labs and emerging decentralized testing needs, which affect product configuration and service models.

Europe, the Middle East and Africa present a diverse regulatory and market environment where single-market strategies rarely apply uniformly. Western European markets often lead in early adoption of integrated laboratory systems and place a high value on formal method validation and cross-border quality harmonization. Regulatory frameworks in the region require careful navigation, prompting vendors to localize clinical evidence and service offerings. Emerging markets within the region may prioritize cost-effective semi-automated solutions that enable incremental capacity expansion and align with public health initiatives.

Asia-Pacific stands out for rapid infrastructure investment, strong manufacturing ecosystems, and an accelerating appetite for genomics and molecular diagnostics. Adoption patterns range from highly advanced urban reference centers that deploy fully automated sequencing and mass spectrometry workflows to decentralized clinical settings that opt for compact, semi-automated platforms. Across all regions, strategic partnerships between vendors and regional distributors, as well as investments in local technical support and training, are critical enablers of sustained adoption and operational performance.

Competitive and collaborative dynamics where product performance, software integration, validation support, and service models determine long-term adoption and vendor preference

Competitive dynamics in automated microbiology are defined by a mix of specialized instrument manufacturers, integrated systems providers, reagent and consumable suppliers, and service organizations. Market leaders differentiate through a combination of instrument performance, software integration, validation support, and global service networks that minimize downtime and ensure traceability. Strategic alliances between instrument OEMs and reagent partners are increasingly common, creating bundled offerings that simplify procurement and validation but also raise questions about vendor lock-in and interoperability.

Innovation is occurring at multiple layers: at the hardware level with more compact, modular instruments designed for decentralized settings; at the assay level with multiplexed molecular tests and robust sample preparation chemistries; and at the software level where analytics, quality control algorithms, and LIMS integration drive operational value. Service models are likewise evolving, with extended warranties, outcome-based service agreements, and cloud-enabled remote diagnostics becoming standard expectations for high-throughput laboratories. Companies that combine deep domain expertise with scalable support infrastructures gain preference among reference labs and hospital networks, while niche innovators continue to capture specialist segments by focusing on unique assay capabilities or cost-optimized workflows.

Partnerships with academic centers and participation in multi-site validation studies also underpin commercial credibility, particularly for technologies that intersect with clinical decision-making. As competition intensifies, vendors that prioritize open architectures, transparent validation data, and end-user training will be better positioned to convert pilot programs into long-term deployments.

Practical and tactical recommendations for leaders that combine phased automation, procurement resilience, interoperability, workforce development, and partnership strategies

Industry leaders must pursue an integrated set of actions that align technology selection with operational resilience and regulatory readiness. First, adopt a phased automation strategy that begins with pilot deployments to validate workflow integration, method transferability, and staff training requirements before scaling to fully automated suites. This reduces implementation risk and preserves flexibility to pivot as assay needs or supply chain conditions change. Second, design procurement and contracting approaches that emphasize total cost of ownership, predictable service levels, and clear spare parts and reagent supply commitments to mitigate tariff and logistics volatility.

Third, invest in software and data interoperability from the outset to enable seamless integration with laboratory information management systems, electronic health records where applicable, and centralized dashboards for performance monitoring. Open interfaces and standardized data formats reduce long-term integration costs and support multi-vendor environments. Fourth, prioritize workforce development by embedding training programs, competency assessments, and cross-training within implementation plans to ensure laboratory personnel can manage automated workflows, interpret results, and maintain instruments.

Finally, cultivate strategic partnerships with validation partners, regional service providers, and regulatory advisors to accelerate market entry and sustain compliance. Scenario planning that accounts for trade policy shifts, reagent supply interruptions, and staffing constraints will help executives maintain continuity and make informed capital allocation decisions in a landscape where speed, reliability, and traceability confer competitive advantage.

A rigorous mixed-methods research approach combining primary stakeholder interviews, peer-reviewed technical evidence, and targeted technology and commercial assessments

The research underpinning this executive summary combined primary qualitative engagements with laboratory directors, procurement leaders, clinical pathologists, and senior R&D scientists alongside a systematic review of technical literature, regulatory guidance documents, and product technical dossiers. Primary interviews were conducted to surface operational pain points, validation practices, and purchasing behaviors, with emphasis on real-world implementation challenges such as sample throughput variability, staff competency, and maintenance logistics. Secondary sources were selected for methodological rigor and included peer-reviewed studies, open regulatory guidance, and vendor technical specifications to triangulate claims about performance and intended use.

Analytical methods prioritized cross-validation between qualitative insights and documented technical evidence to ensure recommendations are grounded in observable practice rather than vendor positioning. Technology assessments evaluated assay performance characteristics, hands-on time, integration requirements, and typical service footprints. Commercial analysis focused on procurement drivers, contractual structures, and distribution models that affect time-to-deployment. Where possible, evidence from multi-site validation studies and clinical performance evaluations was incorporated to evaluate robustness across diverse laboratory settings.

Limitations of the methodology include variability in reporting granularity across jurisdictions and the evolving nature of software-enabled features, which may shift more rapidly than hardware cycles. To mitigate these limitations, the analysis emphasizes durable operational and strategic themes and recommends targeted pilot studies to validate context-specific performance prior to large-scale rollouts.

Synthesis of strategic imperatives and operational realities that define successful automation deployments in clinical, industrial, and research laboratories

Automated microbiology is at an inflection point where technological maturity, operational pressures, and regulatory demands intersect to create new imperatives for laboratory decision-makers. The combination of improved molecular workflows, advanced identification technologies, and smarter software ecosystems is enabling more reliable and scalable testing across clinical, industrial, and research contexts. Adoption pathways will continue to vary by application, end user, and regional context, but common themes-interoperability, supply chain resilience, workforce readiness, and validated performance-consistently determine successful deployments.

Executives and laboratory leaders should view automation as both a technical upgrade and an organizational transformation that requires deliberate change management, cross-functional governance, and incremental risk mitigation. Where tariffs and trade policy considerations introduce procurement complexity, leaders should prioritize flexibility in sourcing and contractual design to preserve operational continuity. Ultimately, the laboratories that translate automation investments into measurable improvements will be those that combine thoughtful pilots, rigorous validation, and ongoing training with strategic partnerships that support long-term serviceability and compliance.

The insights summarized here are intended to guide strategic planning and to highlight practical levers that accelerate the realization of automation benefits while protecting quality and operational resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI and machine learning algorithms for rapid microbial identification and antimicrobial susceptibility testing
  • 5.2. Integration of robotics and automation platforms to streamline sample preparation workflows in clinical microbiology labs
  • 5.3. Development of cloud-based data analytics solutions for real-time monitoring and remote access to microbial testing results
  • 5.4. Emergence of multiplexed microfluidic systems enabling simultaneous detection of multiple pathogens in single assays
  • 5.5. Regulatory approvals and standardization efforts driving implementation of automated systems in diagnostic laboratories

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Automated Microbiology Market, by Technology

  • 8.1. Culture Based
    • 8.1.1. Automated Colony Counters
    • 8.1.2. Automated Culture Systems
    • 8.1.3. Automated Staining & Microscopy
  • 8.2. Flow Cytometry
  • 8.3. Mass Spectrometry
  • 8.4. Molecular Based
    • 8.4.1. Microarray
    • 8.4.2. Next-Gen Sequencing
    • 8.4.3. Pcr/Real-Time Pcr

9. Automated Microbiology Market, by Product

  • 9.1. Consumables & Reagents
  • 9.2. Instruments & Software
    • 9.2.1. Integrated Systems
    • 9.2.2. Laboratory Information Management Systems
    • 9.2.3. Standalone Instruments
  • 9.3. Services

10. Automated Microbiology Market, by Application

  • 10.1. Academic & Research
  • 10.2. Clinical Diagnostics
    • 10.2.1. Genetic Disorders
    • 10.2.2. Infectious Diseases
    • 10.2.3. Oncology
  • 10.3. Environmental Testing
  • 10.4. Food & Beverage
  • 10.5. Pharmaceutical & Biotechnology

11. Automated Microbiology Market, by End User

  • 11.1. Academic & Research Institutions
  • 11.2. Food & Beverage Companies
  • 11.3. Hospitals & Diagnostic Laboratories
    • 11.3.1. Clinics
    • 11.3.2. Private Hospitals
    • 11.3.3. Public Hospitals
  • 11.4. Pharmaceutical Companies
  • 11.5. Reference Laboratories

12. Automated Microbiology Market, by Automation Level

  • 12.1. Fully Automated
  • 12.2. Semi-Automated

13. Automated Microbiology Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Automated Microbiology Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Automated Microbiology Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. bioMerieux SA
    • 16.3.2. Becton, Dickinson and Company
    • 16.3.3. Thermo Fisher Scientific Inc.
    • 16.3.4. Danaher Corporation
    • 16.3.5. Siemens Healthineers AG
    • 16.3.6. Merck KGaA
    • 16.3.7. Sysmex Corporation
    • 16.3.8. PerkinElmer, Inc.
    • 16.3.9. bio-Rad Laboratories, Inc.
    • 16.3.10. Abbott Laboratories

LIST OF FIGURES

  • FIGURE 1. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. AUTOMATED MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. AUTOMATED MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. AUTOMATED MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED COLONY COUNTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED CULTURE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATED STAINING & MICROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY NEXT-GEN SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PCR/REAL-TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CONSUMABLES & REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY STANDALONE INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY SEMI-AUTOMATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL AUTOMATED MICROBIOLOGY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CULTURE BASED, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY MOLECULAR BASED, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS & SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROBIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA AUTOMATED MICROB